IMU imugene limited
Add to My Watchlist 7.69% ! 1.2¢

TA - GAP GAP GAP, page-21

  1. maplelegion
    1,509 Posts.
    lightbulb Created with Sketch. 1105
    clock Created with Sketch.
    07/11/24
    12:46
    Post #: 76498723
    Happened to come across this piece DATED THE 5TH NOV ,on the website ONCODAILY
    https://oncodaily.com/opinion/turning-point-in-cancer-treatment-2024-nov
    Whilst it might be regarded as just another 'motherhood ' statement , when you read and think about the content as below , this is the path that IMU DISTINCTLY seems to be tracking :
    Hopefully , IMU 's time for recognition of success is closing fast :

    Edit

    But today, a new path is emerging—one that favors swift, groundbreaking innovations from smaller, agile biotech firms over the entrenched practices of industry giants.

    This shift couldn’t come at a more crucial time. Cancer patients deserve therapies that do more than maintain the status quo; they need treatments that bring real hope, offering not just prolonged survival but the potential for cures. Advances in immunotherapy, gene editing, and precision medicine are no longer theoretical—they are the tools that can redefine cancer treatment. Yet the dominance of traditional players, who have long controlled regulatory pathways and market access, has slowed the path to these breakthroughs.

    The potential for policy changes under the new administration brings an unprecedented opportunity to recalibrate the biopharma landscape. Streamlined FDA processes and reduced entry barriers can create a market where data-driven progress and patient outcomes take precedence over sheer brand power. Smaller, mission-driven companies, unencumbered by bureaucracy, are ready to lead the way—bringing life-changing treatments to patients faster.


    IMU Price at posting: 4.4¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 28  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms
right-arrow Created with Sketch.
NEWS Pilbara Exploration Identifies High-Grade Gold and Antimony Targets
right-arrow Created with Sketch.
NEWS Bullish Brookside expands with fifth DSU at 'highly sought after' American oil and gas field
right-arrow Created with Sketch.
NEWS Uranium ignites: Is this the start of a supercycle?
right-arrow Created with Sketch.
NEWS Profits after tax down -88%, and shares rocket – what's going on with Collins?
right-arrow Created with Sketch.
NEWS How Do You Trade? Take Our 1-Minute Survey & Share Your Style
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.2¢ 		Change
-0.001(7.69%) 		Mkt cap ! $89.60M
Open High Low Value Volume
1.2¢ 1.3¢ 1.2¢ $140.7K 11.61M

Buyers (Bids)

No. Vol. Price($)
50 9000852 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 6923007 25
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.